Joining The Connect Immune Research Partnership

The Psoriasis Association has recently joined the Connect Immune Research partnership - an innovative, cross-disciplinary initiative focused on advancing autoimmune research.

Established in 2018, Connect Immune Research is a collaborative initiative that brings a growing number of charities together to better understand the common biological/physiological processes underlying autoimmune conditions.

As a new member, the Psoriasis Association will bring expertise to Connect Immune Research, complementing and strengthening the partnership and supporting the vision of a connected research community that advances understanding and treatments for people living with autoimmune conditions.

Click to enlarge

Rachel Connor, Director of Research Partnerships at Breakthrough T1D UK said:

“We are delighted to welcome the Psoriasis Association to this partnership. For the past eight years, Connect Immune Research has demonstrated the power of collaboration across the autoimmune community. By bringing charities together to share expertise and knowledge, we can accelerate progress towards a more connected research landscape—one that delivers meaningful advances for everyone living with one, or multiple, autoimmune conditions.”

Melinda Spencer, Research manager at the Psoriasis Association, added:

“We are delighted to join a research community that shares our commitment to understanding and improving the lives of people affected by immune-mediated conditions. At the Psoriasis Association, we value the opportunity to connect expertise, share insights, and ensure that patient voices help guide meaningful research. Together, we are hopeful that this collaboration will drive progress, deepen understanding, and lead to better outcomes for everyone living with autoimmune conditions.”

More information about our 2025-2026 goals can be found on our research page.